ArticleBlood cancer journal2024

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis.

Fieke W Hoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.